PRMT5 and cancer: By reconstructing an event of genomic deregulation for PRMT5 in CLL, we validated our strategy to identify deregulated cancer driving factors in a highly cell type specific manner and contributed to further understanding of PRMT5 function in chronic lymphocytic leukemia.